Skip to main content

A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.

Publication ,  Journal Article
Surwit, RS; Gilgor, RS; Allen, LM; Duvic, M
Published in: Arch Dermatol
March 1984

Nineteen patients with Raynaud's phenomenon in conjunction with progressive systemic sclerosis were given either prazosin hydrochloride (1 mg orally three times a day) or a placebo for eight weeks, after which the treatment procedure was reversed for four weeks. Prazosin was shown to be effective in reducing both the frequency and the severity of vasospasm reported by the patients.

Duke Scholars

Published In

Arch Dermatol

ISSN

0003-987X

Publication Date

March 1984

Volume

120

Issue

3

Start / End Page

329 / 331

Location

United States

Related Subject Headings

  • Scleroderma, Systemic
  • Raynaud Disease
  • Quinazolines
  • Prazosin
  • Middle Aged
  • Male
  • Humans
  • Female
  • Double-Blind Method
  • Dermatology & Venereal Diseases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Surwit, R. S., Gilgor, R. S., Allen, L. M., & Duvic, M. (1984). A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma. Arch Dermatol, 120(3), 329–331.
Surwit, R. S., R. S. Gilgor, L. M. Allen, and M. Duvic. “A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.Arch Dermatol 120, no. 3 (March 1984): 329–31.
Surwit RS, Gilgor RS, Allen LM, Duvic M. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma. Arch Dermatol. 1984 Mar;120(3):329–31.
Surwit, R. S., et al. “A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.Arch Dermatol, vol. 120, no. 3, Mar. 1984, pp. 329–31.
Surwit RS, Gilgor RS, Allen LM, Duvic M. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma. Arch Dermatol. 1984 Mar;120(3):329–331.

Published In

Arch Dermatol

ISSN

0003-987X

Publication Date

March 1984

Volume

120

Issue

3

Start / End Page

329 / 331

Location

United States

Related Subject Headings

  • Scleroderma, Systemic
  • Raynaud Disease
  • Quinazolines
  • Prazosin
  • Middle Aged
  • Male
  • Humans
  • Female
  • Double-Blind Method
  • Dermatology & Venereal Diseases